Biocept's lung cancer blood test to become more accessible in Mexico
Biocept has entered into a deal with Quest Diagnostics Mexico to expand the reach of its epidermal growth factor receptor (EGRF) mutation detecting liquid biopsy test to lung cancer patients in Mexico. Biocept's liquid biopsy tests for cancer profiling and monitoring help identify cancer mutations, which in this case are EGFR mutations associated with lung cancer. Read More »